| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/08/2002 | US20020107330 Drug delivery compositions and medical devices containing block copolymer |
| 08/08/2002 | US20020107292 Primary composition comprising a lipophilic bioactive compound |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107261 Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors |
| 08/08/2002 | US20020107259 Analgesic combination of oxycodone and SC-58215 |
| 08/08/2002 | US20020107250 Orally deliverable cyclooxygenase-2 inhibitor of low water solubility, for example celecoxib, and a glycol ether, for example diethylene glycol monoethyl ether. |
| 08/08/2002 | US20020107249 Administering a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine of at least about 5000, such as reboxetine; treating and prophylaxis of various psychological and neurological disorders |
| 08/08/2002 | US20020107247 Method of treating sexual disturbances |
| 08/08/2002 | US20020107244 Combination treatment for depression |
| 08/08/2002 | US20020107236 Methods of treating sexual dysfunction associated with hypertension |
| 08/08/2002 | US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation |
| 08/08/2002 | US20020107230 Methods and formulations for the treatment of female sexual dysfunction |
| 08/08/2002 | US20020107225 Use of nucleoside analogues (cytosine or 5-fluorocytosine containing compound) useful for acute or chronic myelogenous leukemia |
| 08/08/2002 | US20020107218 Using inhibitors such as antisense nucleic acids |
| 08/08/2002 | US20020107206 Treatment of acute coronary syndrome with GLP-1 |
| 08/08/2002 | US20020107203 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 08/08/2002 | US20020107193 Therapeutic uses for IP3 receptor-mediated calcium channel modulators |
| 08/08/2002 | US20020107191 Combination drug therapy |
| 08/08/2002 | US20020107181 Novel hepatitis C virus ("HCV") protease inhibitors and pharmaceutical compositions comprising them optionally with viricide ribavirin and interferon |
| 08/08/2002 | US20020107180 Cell surface glycoproteins |
| 08/08/2002 | US20020107178 Methods and preparations for curing clinically ill patients |
| 08/08/2002 | US20020107177 And methods for identifying Factor XIIIa inhibitors by contacting chemical in question with lipoprotein(a) component, a matrix component, and Factor XIIIa; complex formation inhibition indicates activity |
| 08/08/2002 | US20020107174 Microbial inhibitors or as synergistic enhancers of antibiotics and preservatives for cosmetics and other personal care preparations; endotoxin neutralizing proteins (ENPs) of horseshoe crabs |
| 08/08/2002 | US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof |
| 08/08/2002 | US20020106732 Smad6 and uses thereof |
| 08/08/2002 | US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106713 Inhibitors of the inositol polyphosphate 5-phosphatase SHIP2 molecule |
| 08/08/2002 | US20020106671 Identification of a capacitative calcium channel in antigen presenting cells and uses thereof |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106631 Recombinant, active caspases and uses thereof |
| 08/08/2002 | US20020106630 Method of identifying HIBEF51 receptor inhibitors |
| 08/08/2002 | US20020106415 Interleukin-4production inhibitors |
| 08/08/2002 | US20020106374 Compositions and methods for inhibition of HIV-1 infection |
| 08/08/2002 | US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura |
| 08/08/2002 | US20020106369 Method of inhibiting stenosis and restenosis |
| 08/08/2002 | US20020106359 Method and composition for treating prostate cancer |
| 08/08/2002 | US20020106354 Cellular and animal models for diseases associated with altered mitochondrial function |
| 08/08/2002 | US20020106348 Contacting cell with agent that increases intracellular superoxide anion and contacting cell with 2-methoxyestradiol for killing a cell |
| 08/08/2002 | US20020106329 Transdermal dosage form |
| 08/08/2002 | DE10159291A1 Verfahren zur Herstellung eines partiellen oder vollständigen Wirkstoffüberzuges auf und in Implantaten und Onplantaten A process for preparing a partial or complete coating on active ingredient and in implants and Onplantaten |
| 08/08/2002 | DE10104802A1 Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (1) Pharmaceutical formulations containing Thienopirimidine and endothelin receptor antagonist (1) |
| 08/08/2002 | DE10104801A1 Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (2) Pharmaceutical formulations containing Thienopirimidine and endothelin receptor antagonist (2) |
| 08/08/2002 | DE10104800A1 Pharmazeutische Formulierungen enthaltend Pyrazolo[4,3-d]pyrimidine und Endothelin-Rezeptor-Antagonisten Pharmaceutical formulations containing pyrazolo [4,3-d] pyrimidines and endothelin receptor antagonists |
| 08/08/2002 | CA2444661A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/08/2002 | CA2437555A1 Stabilised polymeric aerosols for pulmonary gene delivery |
| 08/08/2002 | CA2436776A1 Hydrogel wound dressing, preparation and use thereof |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk) |
| 08/08/2002 | CA2436748A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | CA2436661A1 Novel nucleic acid and polypeptide molecules |
| 08/08/2002 | CA2436576A1 Treatment of diabetes mellitus using vardenafil |
| 08/08/2002 | CA2436429A1 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 08/08/2002 | CA2436411A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | CA2436245A1 Medicament for protection in radiotherapy |
| 08/08/2002 | CA2436092A1 Modified antibodies and methods of use |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2434808A1 Novel mixtures of microbial enzymes |
| 08/08/2002 | CA2434495A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2434491A1 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | CA2434485A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | CA2433553A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
| 08/08/2002 | CA2432997A1 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | CA2426587A1 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1228769A1 Symbiotic regenerative composition |
| 08/07/2002 | EP1228768A1 Medicament for the protection against thrombotic diseases |
| 08/07/2002 | EP1228755A1 Use of biodegradable microspheres for the delivery of an anticancer agent for the treatment of gliblastoma |
| 08/07/2002 | EP1228367A2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228221A2 Human sphingosine kinase gene |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228091A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228083A2 Therapeutic treatment of androgen receptor driven conditions |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1228080A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 08/07/2002 | EP1228077A1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 08/07/2002 | EP1228037A1 Compounds having mif antagonist activity |
| 08/07/2002 | EP1227859A2 Neurophilin ligands for treating ocular conditions |
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1227846A2 Methods for inhibiting neurofibromatosis type 1 (nf1) |
| 08/07/2002 | EP1227841A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227830A1 Method of inducing angiogenesis |
| 08/07/2002 | EP1227828A1 Viruses for the treatment of cellular proliferative disorders |
| 08/07/2002 | EP1227821A1 Therapeutic compositions and methods of use thereof |
| 08/07/2002 | EP1227820A2 Oligosaccharide aldonic acids and their topical use |
| 08/07/2002 | EP1227814A1 Hormonal composition based on a progesterone and an oestrogen and use thereof |
| 08/07/2002 | EP1227810A1 Treating cancer by increasing intracellular malonyl coa levels |
| 08/07/2002 | EP1227808A2 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 08/07/2002 | EP1227807A2 Irrigation solution and method for inhibition of pain and inflammation |
| 08/07/2002 | EP1227806A1 Pharmaceutical formulation containing tolterodine and its use |
| 08/07/2002 | EP1227804A2 Use of an aldosterone antagonist for treating restenosis |
| 08/07/2002 | EP1227803A2 Methods and compounds for inhibiting amyloid deposits |